BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma Research

Echosens and Boehringer Ingelheim Expand Partnership to Address the Growing Burden of MASH

As metabolic dysfunction-associated steatohepatitis (MASH) emerges as one of the most dangerous and underdiagnosed drivers of liver failure—affecting...

June 10, 2025 | News

MGI Expands Partnership with Fiocruz’s UNADIG to Advance Genetic Sequencing in Brazil

MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, has just expanded its partne...

June 06, 2025 | News

Innovent and HUTCHMED’s Sintilimab-Fruquintinib Combo Accepted for NMPA Review in Advanced Renal Cell Carcinoma

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

June 05, 2025 | News

Elpis Biopharmaceuticals and Singapore General Hospital Partner to Advance Next-Gen CAR-γδT Cell Therapies for AML and Multiple Myeloma

Elpis Biopharmaceuticals, a clinical-stage cell therapy company developing bispecific armored CAR-T therapies for solid tumors, today announced entry into ...

June 05, 2025 | News

SCIEX Launches ZenoTOF 8600 System to Redefine Mass Spectrometry Quantitation Across Omics Research

SCIEX, a global leader in life science analytical technologies and operating company of Danaher Corporation (NYSE: DHR), launches the ZenoTOF 86...

June 04, 2025 | News

Thermo Fisher Launches Orbitrap Astral Zoom and Excedion Pro MS to Accelerate Precision Research in Alzheimer's, Cancer, and Biopharma

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced the launch of the Thermo Scientific™ Orbitrap™ ...

June 03, 2025 | News

Clarivate and CAPES Renew Partnership to Expand Access to Research Intelligence Across 400+ Institutions in Brazil

Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, announced the renewal of its multi-year partnership with&nb...

June 03, 2025 | News

Kexing Biopharm’s GB18 Receives IND Approval in China and U.S. for Cancer Cachexia Treatment

Kexing Biopharm (688136.SH) announced that the National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) applica...

May 30, 2025 | News

Adalvo Inks Licensing Deal with Formosa Pharmaceuticals for Novel Ophthalmic Steroid in Europe and Brazil

Adalvo announces the signing of an exclusive licensing agreement with Formosa Pharmaceuticals for the commercialisation of Clobetasol propio...

May 29, 2025 | News

DualityBio and Avenzo Receive FDA IND Clearance for Novel EGFR/HER3 Bispecific ADC

Duality Biotherapeutics partner Avenzo Therapeutics, Inc. a clinical-stage biotechnology company developing next-generation oncology therapies, announced c...

May 23, 2025 | News

BioMed X and Boehringer Ingelheim Launch Global Call for Next-Gen Intraocular Biologics Platform

The BioMed X Institute announced today the launch of a new global call for research proposals in collaboration with Boehringer Ingelhei...

May 21, 2025 | News

Xuanzhu Biopharmaceutical’s Bireociclib (Xuanyuening®) Approved in China, Setting New Benchmark in HR+/HER2- Breast Cancer Treatment

National Medical Products Administration attracted widespread attention in the oncology community and the pharmaceutical market. Bireociclib tablets (trade...

May 19, 2025 | News

InnoCare Pharma Doses First Patient in Phase II/III Trial of Soficitinib for Vitiligo in China

InnoCare Pharma a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first patient has...

May 19, 2025 | News

Streamlining Biologics QC: How Waters’ Empower-MALS Integration Is Reshaping Analytical Workflows

Waters Corporation is tackling the complexity of biologics quality control with the integration of Multi-Angle Light Scattering (MALS) into its Empower&tr...

May 16, 2025 | Interaction

Stay Connected